FDA — authorised 9 February 2004
- Application: NDA021166
- Marketing authorisation holder: ASCEND THERAPS US
- Local brand name: ESTROGEL
- Indication: GEL — TOPICAL
- Status: approved
FDA authorised Transdermal estrogen on 9 February 2004
Yes. FDA authorised it on 9 February 2004.
ASCEND THERAPS US holds the US marketing authorisation.